Reduced total fluence photodynamic therapy of choroidal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 41/00 (2006.01)

Patent

CA 2437557

The invention relates to the use of reduced fluence rate PDT to treat neovasculature, particularly choroidal neovasculature (CNV). Reduced fluence rate PDT decreases the likelihood of molecular oxygen being the limiting factor in the photodynamic reaction so that the concentration of either photons (light intensity) or photosensitizer in the target tissue controls the photodynamic reaction.

L'invention concerne l'utilisation de la thérapie photodynamique à débit de fluence réduit (PDT) afin de traiter la néovascularisation, notamment la néovascularisation choroïdienne (NCR). La thérapie photodynamique à débit de fluence réduit (PDT) diminue les probabilités que l'oxygène moléculaire soit le facteur limitatif dans la réaction photodynamique de sorte que la concentration de photons (intensité lumineuse) ou de photosensibilisateur dans le tissu cible règle la réaction photodynamique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Reduced total fluence photodynamic therapy of choroidal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduced total fluence photodynamic therapy of choroidal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduced total fluence photodynamic therapy of choroidal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1920156

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.